Analysts in Media Announces Release of Q3 Edition of Future Pharmaceuticals
New York, NY, August 24, 2006 --(PR.com)-- Today, Analysts In Media, Inc. (AIM) released the Q3 August 2006 edition of Future Pharmaceuticals (FP) a high-level publication both online and in print, designed to provide senior-level business and technology executives with an in-depth analysis of, and key insight into market trends and innovative technologies within the Pharmaceutical and Biotechnology industry.
This Q3 edition of FP features keynote editorial thought leadership from the most respected industry analysts, experts, and solution providers within the Pharmaceutical and Biotechnology world. The leading topics of discussion in this edition include Drug Discovery, Clinical Trails, Sales and Marketing, Learning and Training, and Conferences and Meetings.
Featured editorial contributors include:
Nancy Grey, Director of Pharmacovigilance Education and Process Documentation in the Safety and Risk Management Organization, Pfizer.
Janice Arnold, Associate Director of Marketing and Sales Information Analysis, Daiichi Sankyo
Rebecca Kush, President, Clinical Data Interchange Standards Consortium (CDISC)
Daniel C. Sullivan, Associate Director, National Cancer Institute
Drug Discovery: Dr. Daniel C. Sullivan, Associate Director, National Cancer Institute, Fred Vinick, Senior VP of Drug Discovery. Genzyme Corporation, and Samuel Aronson, Director of IT, Harvard Medical Center
Clinical Trials: Rebecca Kush, President, CDISC, Kenneth Getz, Senior Research Fellow, Tufts Center for the Study of Drug Development, and Roni Thaler, President and CEO, CISCRP
Sales and Marketing: Janice Arnold, Associate Director of Marketing and Sales Information Analysis, Daiichi Sankyo
Learning and Training: Nancy Grey, Director of Pharmacovigilance Education Documentation in the Safety and Risk Management Organization, Pfizer, Stephen McGuffin, Assistant VP Sales Training and Management Development, Wyeth, and Don Kraft Associate Director of Human Resources (Learning and Organizational Development Department), Genentech
"We are delighted that these thought leaders have been kind enough to lend their expertise to this edition of the Future Pharmaceuticals,” says Amir Nikaein, CEO. “This further cements our ambition to make FP the leading information resource for buyers of technology and services within the Pharmaceutical and Biotechnology industry."
The publication is available in both print and online at www.futurepharmaus.com
To register for a free subscription to Future Phatmaceuticals, please go to:
http://www.futurepharmaus.com/register.php
About Future Pharmaceuticals:
Published by Analysts in Media, Inc., Future Pharmaceuticals has forged powerful relationships with key industry leaders to provide a platform for successful brand recognition, and for senior decision-makers to have the means to procure and plan implementation strategies based on the topics covered. Positioned to be an authoritative resource within top pharmaceutical companies as well as small, specialty, and biotech, Future Pharmaceuticals is geared to create a deep penetration into a highly targeted and responsive audience, bridging the gap between the industries' top issues and the solutions top-tier vendors can provide.
www.futurepharmaus.com
About Analysts In Media
Analysts In Media, Inc. is a leading global provider of specialized information services for the professional and enthusiast markets, actively bringing buyers and sellers together across targeted media channels – publications, events and online.
www.analystsinmedia.com
###
This Q3 edition of FP features keynote editorial thought leadership from the most respected industry analysts, experts, and solution providers within the Pharmaceutical and Biotechnology world. The leading topics of discussion in this edition include Drug Discovery, Clinical Trails, Sales and Marketing, Learning and Training, and Conferences and Meetings.
Featured editorial contributors include:
Nancy Grey, Director of Pharmacovigilance Education and Process Documentation in the Safety and Risk Management Organization, Pfizer.
Janice Arnold, Associate Director of Marketing and Sales Information Analysis, Daiichi Sankyo
Rebecca Kush, President, Clinical Data Interchange Standards Consortium (CDISC)
Daniel C. Sullivan, Associate Director, National Cancer Institute
Drug Discovery: Dr. Daniel C. Sullivan, Associate Director, National Cancer Institute, Fred Vinick, Senior VP of Drug Discovery. Genzyme Corporation, and Samuel Aronson, Director of IT, Harvard Medical Center
Clinical Trials: Rebecca Kush, President, CDISC, Kenneth Getz, Senior Research Fellow, Tufts Center for the Study of Drug Development, and Roni Thaler, President and CEO, CISCRP
Sales and Marketing: Janice Arnold, Associate Director of Marketing and Sales Information Analysis, Daiichi Sankyo
Learning and Training: Nancy Grey, Director of Pharmacovigilance Education Documentation in the Safety and Risk Management Organization, Pfizer, Stephen McGuffin, Assistant VP Sales Training and Management Development, Wyeth, and Don Kraft Associate Director of Human Resources (Learning and Organizational Development Department), Genentech
"We are delighted that these thought leaders have been kind enough to lend their expertise to this edition of the Future Pharmaceuticals,” says Amir Nikaein, CEO. “This further cements our ambition to make FP the leading information resource for buyers of technology and services within the Pharmaceutical and Biotechnology industry."
The publication is available in both print and online at www.futurepharmaus.com
To register for a free subscription to Future Phatmaceuticals, please go to:
http://www.futurepharmaus.com/register.php
About Future Pharmaceuticals:
Published by Analysts in Media, Inc., Future Pharmaceuticals has forged powerful relationships with key industry leaders to provide a platform for successful brand recognition, and for senior decision-makers to have the means to procure and plan implementation strategies based on the topics covered. Positioned to be an authoritative resource within top pharmaceutical companies as well as small, specialty, and biotech, Future Pharmaceuticals is geared to create a deep penetration into a highly targeted and responsive audience, bridging the gap between the industries' top issues and the solutions top-tier vendors can provide.
www.futurepharmaus.com
About Analysts In Media
Analysts In Media, Inc. is a leading global provider of specialized information services for the professional and enthusiast markets, actively bringing buyers and sellers together across targeted media channels – publications, events and online.
www.analystsinmedia.com
###
Contact
Analysts In Media
Alaina Cagliostro
646-747-0560
www.futurepharmaus.com
www.analystsinmedia.com
Alaina Cagliostro
646-747-0560
www.futurepharmaus.com
www.analystsinmedia.com
Contact
Categories